Corporate Tech Investors

Novartis BioVenture Fund

Novartis BioVenture Fund is a corporate VC that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

The Novartis Venture Fund is based on the conviction that economic growth and the creation of new jobs can be achieved in the long run only if new entrepreneurial initiatives develop and promising ideas become a business reality. With an inital venture capital of CHF 175 million and USD 100 million, the Novartis Venture Fund supports new business projects that show exemplary entrepreneurial and innovative spirit in future-oriented areas, especially in the field of Health Sciences.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/11/2021

Transaction History

Our records indicate that Novartis BioVenture Fund invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Principal

Juliette Audet

        

Managing Director

Laura Brass

        

Managing Director

Florent Gros

        

Principal

Anja König

        

Managing Director

Campbell Murray

        

Managing Director

Steven Weinstein

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Novartis BioVenture Fund has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Novant Health | Novartis Institutes for BioMedical Research

Share this article

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary